I got carried away. (Just over-optimistic, I guess!)

NIH is not recommending Ivermectin as a COVID-19 treatment,
but no longer not recommending it, declaring itself "neither for nor
against" it. So the drug is now a therapeutic option for US doctors
treating COVID-19. 

So why did NIH revise its stand? If it was due to the abundant
evidence that Ivermectin works, why has it not done the same 
with HCQ? 

Too bad we don't live in a democracy, where such policies would
be determined on the basis of some public give-and-take, and
revised or modified transparently.  




On Jan 16, 2021, at 1:50 PM, Mark Crispin Miller <markcrispinmiller@protonmail.ch> wrote:

https://covid19criticalcare.com/wp-content/uploads/2021/01/FLCCC-PressRelease-NIH-Ivermectin-in-C19-Recommendation-Change-Jan15.2021-final.pdf




Sent with ProtonMail Secure Email.